Stimulation of the immune system by different TBE-virus vaccines

1998, FSME-Impfstoff ENCEPUR K vom Markt, Pharm. Z., 143, 1470 Benda, 1962, Evaluation of the immunogenic efficiency of tick-borne encephalitis virus vaccine, 317 Benda, 1961, Study of the possibility of preparing a vaccine against tick-borne encephalitis using tissue culture methods. V. Experimental data for the evaluation of the efficiency of formol-treated vaccines in laboratory animals, Acta Virol., 5, 37 Bock, 1990, A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study, Vaccine, 8, 22, 10.1016/0264-410X(90)90172-I Dinarello, 2000, Proinflammatory cytokines, Chest, 118, 503, 10.1378/chest.118.2.503 Girgsdies, 1996, Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study, Vaccine, 14, 1421, 10.1016/S0264-410X(96)00081-3 Harabacz, 1992, A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens, Vaccine, 10, 145, 10.1016/0264-410X(92)90003-3 Heinz, 1983, A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies, Virology, 126, 525, 10.1016/S0042-6822(83)80010-5 Heinz, 1980, Preparation of a highly purified vaccine against tick-borne encephalitis by continuous low ultracentrifugation, J. Med. Virol., 6, 213, 10.1002/jmv.1890060304 Herman, 1991, Superantigens: mechanism of T cell stimulation and role in immune responses, Annu. Rev. Immunol., 9, 745, 10.1146/annurev.iy.09.040191.003525 Hirano, 1992, The biology of interleukin-6, Chem. Immunol., 51, 153, 10.1159/000319085 Klockmann, 1989, Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine, J. Biol. Stand., 17, 331, 10.1016/S0092-1157(89)80004-6 Klockmann, 1991, Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization, Vaccine, 9, 42, 10.1016/0264-410X(91)90315-W Kunz, 1980, Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis, J. Med. Virol., 6, 103, 10.1002/jmv.1890060202 Kunz, 1986, Die Frühsommer-Meningoenzephalitis, 275 Kunz, 1992, Tick-borne encephalitis in Europe, Acta Leiden, 60, 1 Marth, 2001, Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination, Vaccine, 20, 532, 10.1016/S0264-410X(01)00329-2 Miethke, 1993, Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1, Eur. J. Immunol., 23, 1494, 10.1002/eji.1830230715 Parsonnet, 1989, Mediators in the pathogenesis of TSS: overview, Rev. Infect. Dis., 11, S263, 10.1093/clinids/11.Supplement_1.S263 Reiser, 1984, Identification, purification, and some physicochemical properties of staphylococcal enterotoxin C3, Infect. Immun., 45, 625, 10.1128/IAI.45.3.625-630.1984 Rosenkranz, 1997, Can we reduce the dose of a vaccine?, Controlled Clinical Trials, 18, 43, 10.1016/S0197-2456(95)00261-8 Smorodintsev, 1941, Experimenteller und epidemiologischer Beitrag zur aktiven Immunisierung gengen die Frühsommer-Meningo-Encephalitis, Arch. Ges. Virusforsch., 3, 1, 10.1007/BF01240711 Suk, 1996, Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma, Immunology, 87, 551, 10.1046/j.1365-2567.1996.500561.x Tracey, 1994, Tumor necrosis factor. A pleiotropic cytokine and therapeutic target, Annu. Rev. Med., 45, 491, 10.1146/annurev.med.45.1.491 WHO, 1986, Tick-borne encephalitis and haemorrhagic fever with renal syndrome in Europe, 104 Zent, 2002, Immediate allergic reactions after vaccination — a post-marketing surveillance review, Eur. J. Pediatr., 161, 21, 10.1007/s00431-001-0853-0 Zent, 2003, Safety, immunogenicity and tolerability of a new paediatric Tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer, Vaccine, 10.1016/S0264-410X(03)00421-3 Zhengyin, 1999, Production of tumour necrosis factor alpha in human T-lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C, Infect. Immun., 67, 6611, 10.1128/IAI.67.12.6611-6618.1999